Effects of non-surgical periodontal therapy on glycemic control of Type 2 Diabetes Mellitus: A literature review
DOI:
https://doi.org/10.59334/ROV.v1i32.375Keywords:
Periodontal diseases, Diabetes Mellitus, glycemic index, glycated hemoglobin A, interleukins, tumor necrosis factor-alpha, periodontal medicine, periodontitisAbstract
Objective: To know the relationship between periodontal disease and type 2 diabetes mellitus in the control of blood glucose.
Design and research methods: A bibliographic search was conducted using a database (PubMed) with english language restriction, looking for the most recent research and with the largest number of research subjects.
Results: The articles reviewed coincide in the treatment of periodontal disease improves glycemic control in patients with diabetes mellitus type 2, with an average of 0.69% in the level of glycosylated hemoglobin (HbA1c).
Conclusions: Periodontal treatment improves glycemic control in patients with Type 2 Diabetes Mellitus, as well as the number of inflammatory cells (such as IL6 and TNF-α) that cause alterations in insulin activity
Downloads
References
Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44:127–153. https://doi.org/10.1111/j.1600-0757.2006.00193.x
World Health Organization. Global Report on Diabetes 2016. Geneva:World Health Organization; 2016.
Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005;366:1809–1820. https://doi.org/10.1016/S0140-6736(05)67728-8
Demmer RT, Papapanou PN. Epidemiologic patterns of chronic and aggressive periodontitis. Periodontol 2000. 2010;53:28–44. https://doi.org/10.1111/j.1600-0757.2009.00326.x
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycemic control in patients with non insulin dependent diabetes mellitus. J Periodontol 1996;67(10 Suppl):1085–93. https://doi.org/10.1902/jop.1996.67.10s.1085
Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801. https://doi.org/10.1172/JCI29069
Leite RS, Marlow NM, Fernandes JK (2013) Oral health and type 2 diabetes. Am J Med Sci 345: 271-273. https://doi.org/10.1097/MAJ.0b013e31828bdedf
Firatli E (1997) The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. J Periodontol 68: 136-140. https://doi.org/10.1902/jop.1997.68.2.136
Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, et al. (1994) Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 65: 260-267. https://doi.org/10.1902/jop.1994.65.3.260
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, et al. (1996) Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67: 1085-1093. https://doi.org/10.1902/jop.1996.67.10s.1085
Grossi SG (2001) Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol 6: 138-145. https://doi.org/10.1902/annals.2001.6.1.138
Hirano, T. et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73–76 (1986), https://doi.org/10.1038/324073a0
Pal, M., Febbraio, M. A. & Whitham, M. From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. Immunol Cell Biol 92, 331–339 (2014), https://doi.org/10.1038/icb.2014.16
Febbraio, M. A., Hiscock, N., Sacchetti, M., Fischer, C. P. & Pedersen, B. K. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643–1648 (2004). https://doi.org/10.2337/diabetes.53.7.1643
Nieto-Vázquez, I., Fernández-Veledo, S., de Alvaro, C. & Lorenzo, M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 57, 3211–3221, 2008, https://doi.org/10.2337/db07-1062
Senn, J. J., Klover, P. J., Nowak, I. A. & Mooney, R. A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391–3399, 2002. https://doi.org/10.2337/diabetes.51.12.3391
Ellingsgaard, H. et ál. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17, 1481–1489, 2011. https://doi.org/10.1038/nm.2513
Suzuki, T. et al. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 60, 537–547, 2011. https://doi.org/10.2337/db10-0796
Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleu-kin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745–E751, 2001. https://doi.org/10.1152/ajpendo.2001.280.5.E745
Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87:2084 –2089, 2002, https://doi.org/10.1210/jcem.87.5.8450
Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W: Interleu-kin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517–520, 2000. https://doi.org/10.2337/diabetes.49.3.517
Fernández-Veledo S, Nieto-Vazquez I, Rondinone CM, Lorenzo M. Liver X receptor agonists ameliorate TN-Falpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphata-se-1B gene expression. Diabetologia. 2006 Dec; 49(12):3038-48. Epub 2006 Oct 27. PubMed PMID: 17072583. https://doi.org/10.1007/s00125-006-0472-4
Salman S, Khan K, Salman F, Hameed M. Effect Of Non- Surgical Periodontal Treatment On Glycemic Control Among Type 2 Diabetes Mellitus Patients With Periodontitis. J Ayub Med Coll Abbottabad. 2016 Oct-Dec;28(4):442-445. PubMed PMID: 28586617.
Westfelt E, Rylander H, Blohmé G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996;23:92-100. https://doi.org/10.1111/j.1600-051X.1996.tb00540.x
Sun WL, Chen LL, Zhang SZ, Ren YZ, Qin GM. Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis. Arch Oral Biol. 2010;55:970-4. https://doi.org/10.1016/j.archoralbio.2010.08.001
Marigo L, Cerreto R, Giuliani M, Somma F, Lajolo C, Cordaro M. Diabetes mellitus: biochemical, histological and microbiological aspects in periodontal disease. Eur Rev Med Pharmacol Sci. 2011;15:751-8.
Correa FO, Gonzalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol. 2010;37:53-8. https://doi.org/10.1111/j.1600-051X.2009.01498.x
Kammoun HL, Kraakman MJ, Febbraio MA. Adipose tissue inflammation in glucose metabolism. Rev Endocr Metab Disord. 2014;15:31-44. https://doi.org/10.1007/s11154-013-9274-4
Grover HS, Luthra S. Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease. J Indian Soc Periodontol. 2013;17:292-301. https://doi.org/10.4103/0972-124X.115642
Goel K, Pradhan S, Bhattarai MD. Effects of nonsurgical periodontal therapy in patients with moderately controlled type 2 diabetes mellitus and chronic periodontitis in Nepalese population. Clin Cosmet Investig Dent. 2017 Jul 17;9:73-80. doi: 10.2147/CCIDE.S138338. eCollection 2017. PubMed PMID: 28761379; PubMed Central PMCID: PMC5522660. https://doi.org/10.2147/CCIDE.S138338
The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009; 32 (7): 1327-1334. https://doi.org/10.2337/dc09-9033
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Edgar Becerra-Núñez, Alejandro García-Muñoz, Miguel Angel Quiróz-Pérez, Felipe Ibarra-González
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Odontología Vital agree to the following terms:
- Authors retain the copyright and grant Universidad Latina de Costa Rica the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the Odontología Vital's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
